Find your competitive advantage through custom buffer formulations for CAR-T manufacturing
Cell & Gene Therapy 2022; 8(11), 1499;
Synergize your tools to generate process insights Watch the video or read the poster to find out how to:
- Reduce time-to-market and Cost of Goods with automation
- Enable multi-parallel experimentation using scale-down bioreactors and bioanalytical tools
- Consolidate data analytics to allow for better process knowledge
- Scale-up with seamless transitions
Rohit Saklecha is a Portfolio Manager with experience in research & development for stem cell therapies. Rohit has over 7 years of experience working working with stem cells from many different sources prior to joining Sartorius. He was most recently a Research Scientist at Intrexon working on pushing the boundaries for a stem cell therapy.
Andreas Castillo is a Portfolio Manager with experience in autologous manufacturing of CAR-T therapies. With over 8 years of gene editing experience prior to joining Sartorius, Andres was most recently a Research Scientist at Seattle Children's Hospital working in CAR-T manufacturing.